These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1209511)

  • 1. [Antibody development in influenza vaccination with a polyvalent aluminum oxide adsorbed vaccine].
    Dorow P
    Ther Ggw; 1975 Nov; 114(11):1934-44. PubMed ID: 1209511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody level and antibody spectrum following vaccination of man with polyvalent adsorbed influenza vaccines].
    Ricken D; Oberhoffer G; Heinen H; Posch J
    Med Klin; 1966 Jan; 61(3):92-6. PubMed ID: 5982902
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody formation after vaccination with adsorbed and non-adsorbed A/New Jersey/8/76 influenza vaccines.
    Schenk KD; Pressler K; Sarateanu DE; Peukert M; Ehrengut W; Schnitker J
    Pharmatherapeutica; 1982; 3(3):201-8. PubMed ID: 7134228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of thymus extract TP on antibody formation in rats irradiated and immunized with influenza vaccine, strain A2].
    Milcu SM; Boeru V; Babeş V; Panaitiu G; Potop I
    Stud Cercet Endocrinol; 1973; 24(6):483-9. PubMed ID: 4769475
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influenza vaccination and antibody development in man].
    Potel J
    Med Klin; 1966 Jan; 61(3):87-91. PubMed ID: 5982901
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the antigenicity and tolerance of an influenza aluminium oxide adsorbate vaccine with an aqueous vaccine.
    Pressler K; Peukert M; Schenk D; Borgoño M
    Pharmatherapeutica; 1982; 3(3):195-200. PubMed ID: 7134227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of humoral immune response to influenza vaccines by BCG.
    Zykov MP; Subbotina TI
    Acta Virol; 1985 Sep; 29(5):403-9. PubMed ID: 2866694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA; Sockrider M; Castro M; Holbrook JT; Tonascia J; Wise R; Atmar RL;
    J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
    Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
    Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influenza vaccination, development and testing of an influenza vaccine].
    Belian W; Henne K; Hölzer E; Wachtel S; Neubert G; Hantsch H; Rux C
    Dtsch Gesundheitsw; 1972 Nov; 27(48):2286-8. PubMed ID: 4656835
    [No Abstract]   [Full Text] [Related]  

  • 11. [Formation of humoral antibodies using different vaccination modes with an influenza virus adsorbate vaccine].
    Pechmann HC; Klett G; Willkommen H; Tiller FW; Thilo W
    Z Arztl Fortbild (Jena); 1980 Nov; 74(22):1073-7. PubMed ID: 7233993
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of the immunogenicity of aqueous versus aluminium phosphate adsorbed split influenza vaccine C.I.
    Ioniţă E; Lupulescu E; Alexandrescu V; Maţepiuc M; Constantinescu C; Creţescu L; Velea L
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):265-73. PubMed ID: 2519636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of A1PO4 on antibody response.
    Hennessy AV; Patno ME; Davenport FM
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):396-8. PubMed ID: 5165762
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative antigenic potency in man of polyvalent influenza virus vaccines containing isolated hemagglutinins or intact viruses.
    Hennessy AV; Davenport FM
    J Immunol; 1966 Aug; 97(2):235-8. PubMed ID: 5921312
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on adsorption vaccines. I. Examination of the course of gamma-aluminum-oxide resorption from deposits of PR 8 influenza virus gamma-aluminum-oxide vaccines].
    HENNEBERG G; DRESCHER J
    Zentralbl Bakteriol Orig; 1956 Dec; 167(4):310-26. PubMed ID: 13410040
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibody response to anti-influenza vaccination with vaccine purified by differential ultracentrifugation and with vaccine purified by zonal ultracentrifugation].
    Verde F; Frezza G; Russo V; Visconti M
    Boll Soc Ital Biol Sper; 1973 Feb; 49(4):178-81. PubMed ID: 4779761
    [No Abstract]   [Full Text] [Related]  

  • 18. Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly.
    Ruf BR; Colberg K; Frick M; Preusche A
    Infection; 2004 Aug; 32(4):191-8. PubMed ID: 15293073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
    Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
    Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiments with depot vaccines].
    Henneberg G
    Arzneimittelforschung; 1965 Sep; 15(9):1003-8. PubMed ID: 4955784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.